Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jan 19;13(2):578.
doi: 10.3390/jcm13020578.

Primary Lateral Sclerosis: An Overview

Affiliations
Review

Primary Lateral Sclerosis: An Overview

Veria Vacchiano et al. J Clin Med. .

Abstract

Primary lateral sclerosis (PLS) is a rare neurodegenerative disorder which causes the selective deterioration of the upper motor neurons (UMNs), sparing the lower motor neuron (LMN) system. The clinical course is defined by a progressive motor disability due to muscle spasticity which typically involves lower extremities and bulbar muscles. Although classically considered a sporadic disease, some familiar cases and possible causative genes have been reported. Despite it having been recognized as a rare but distinct entity, whether it actually represents an extreme end of the motor neuron diseases continuum is still an open issue. The main knowledge gap is the lack of specific biomarkers to improve the clinical diagnostic accuracy. Indeed, the diagnostic imprecision, together with some uncertainty about overlap with UMN-predominant ALS and Hereditary Spastic Paraplegia (HSP), has become an obstacle to the development of specific therapeutic trials. In this study, we provided a comprehensive analysis of the existing literature, including neuropathological, clinical, neuroimaging, and neurophysiological features of the disease, and highlighting the controversies still unsolved in the differential diagnoses and the current diagnostic criteria. We also discussed the current knowledge gaps still present in both diagnostic and therapeutic fields when approaching this rare condition.

Keywords: ALS; hereditary spastic paraplegia; motor neuron disease; primary lateral sclerosis; review.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests in relation to this work. R.L. reports consultation fees (Alfasigma, Amicus Therapeutics s.r.l.), lecture fees (SIMG Service, Adnkronos Salute unipersonale s.r.l., Fondazione Società Italiana di Neurologia, LT3 s.r.l., First Class s.r.l.), advisory board fees (Argon Healthcare s.r.l., Editree Eventi s.r.l., PREX s.r.l., LT3 s.r.l.), congress chair fees (DOC Congress s.r.l.), and scientific meeting organization chair fees (First Class s.r.l., I & C s.r.l.). Other authors: No disclosures.

Figures

Figure 1
Figure 1
Diagram showing the possible genetic work-up in PLS (only genes for which pathogenic variants have been reported are mentioned).
Figure 2
Figure 2
Current diagnostic criteria for PLS [7]. UMN: upper motor neuron; LMN: lower motor neuron. * Minimally increased insertional activity and positive sharp waves or fibrillation potentials in extremity muscles are allowed.
Figure 3
Figure 3
MRI in a PLS patient. (A) Sagittal T1 sequence showing atrophy of primary motor cortex with enlargement of central sulcus (white arrow). (B) Coronal flair sequence showing bilateral corticospinal tract hyperintensities (black arrows).

References

    1. Eisean A.A. Chapter 16 Primary lateral sclerosis. Handb. Clin. Neurol. 2007;82:315–325. - PubMed
    1. Erb W.H. Ueber einen wenig bekannen spinalen symptomencomplex. Berl. Klin. Wochenschr. 1875;12:357–359.
    1. Barohn R.J., Fink J.K., Heiman-Patterson T., Huey E.D., Murphy J., Statland J.M., Turner M.R., Elman L. The clinical spectrum of primary lateral sclerosis. Amyotroph. Lateral Scler. Front. Degener. 2020;21((Suppl. 1)):3–10. doi: 10.1080/21678421.2020.1837178. - DOI - PubMed
    1. Finegan E., Chipika R.H., Shing S.L.H., Hardiman O., Bede P. Primary lateral sclerosis: A distinct entity or part of the ALS spectrum? Amyotroph. Lateral Scler. Front. Degener. 2019;20:133–145. doi: 10.1080/21678421.2018.1550518. - DOI - PubMed
    1. Barceló M.A., Povedano M., Vázquez-Costa J.F., Franquet Á., Solans M., Saez M. Estimation of the prevalence and incidence of motor neuron diseases in two Spanish regions: Catalonia and Valencia. Sci. Rep. 2021;11:6207. doi: 10.1038/s41598-021-85395-z. - DOI - PMC - PubMed